Cargando…

Characterization of SNARE Cleavage Products Generated by Formulated Botulinum Neurotoxin Type-A Drug Products

The study evaluated substrate cleavage product(s) generated by three botulinum neurotoxin serotype A (BoNT/A) medicinal drug products utilizing a novel and highly specific, light-chain activity, high-performance liquid chromatography (LCA-HPLC) method. Samples were reacted with a commercially availa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hunt, Terrence, Rupp, David, Shimizu, Gary, Tam, Karen, Weidler, Julia, Xie, Jack
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153282/ https://www.ncbi.nlm.nih.gov/pubmed/22069680 http://dx.doi.org/10.3390/toxins2082198

Ejemplares similares

Botulinum neurotoxin formulations: overcoming the confusion
por: Samizadeh, Souphiyeh, et al.
Publicado: (2018)

Botulinum neurotoxin formulations: overcoming the confusion [Corrigendum]
Publicado: (2018)

High Conservation of Tetanus and Botulinum Neurotoxins Cleavage Sites on Human SNARE Proteins Suggests That These Pathogens Exerted Little or No Evolutionary Pressure on Humans
por: Carle, Stefan, et al.
Publicado: (2017)

Clostridial Neurotoxins: Mechanism of SNARE Cleavage and Outlook on Potential Substrate Specificity Reengineering
por: Binz, Thomas, et al.
Publicado: (2010)

The destructive effect of botulinum neurotoxins on the SNARE protein: SNAP-25 and synaptic membrane fusion
por: Lu, Bin
Publicado: (2015)

Comparison of botulinum neurotoxin type A formulations in Asia
por: Frevert, Jürgen, et al.
Publicado: (2018)

Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity
por: Fonfria, Elena, et al.
Publicado: (2018)

Posttranslational Regulation of Botulinum Neurotoxin Production in Clostridium botulinum Hall A-hyper
por: Inzalaco, Heather N’te, et al.
Publicado: (2021)

On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015)

Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
por: Frevert, Jürgen
Publicado: (2015)

Production and characterization of cell-penetrating recombinant botulinum neurotoxin type A
por: Wei, Xuan, et al.
Publicado: (2023)

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)

Cleavage of SNAP25 and Its Shorter Versions by the Protease Domain of Serotype A Botulinum Neurotoxin
por: Mizanur, Rahman M., et al.
Publicado: (2014)

Growth cone collapse and inhibition of neurite growth by Botulinum neurotoxin C1: a t-SNARE is involved in axonal growth
Publicado: (1996)

Production and Characterisation of a Neutralising Chimeric Antibody against Botulinum Neurotoxin A
por: Prigent, Julie, et al.
Publicado: (2010)

Is it Possible to Accurately Determine Content of Botulinum Neurotoxin Type A in Drug Products?
por: Sesardic, Dorothea
Publicado: (2012)

Zebrafish Sensitivity to Botulinum Neurotoxins
por: Chatla, Kamalakar, et al.
Publicado: (2016)

Use of Botulinum Neurotoxin in Ophthalmology
por: Başar, Emel, et al.
Publicado: (2016)

Antipruritic Effects of Botulinum Neurotoxins
por: Gazerani, Parisa
Publicado: (2018)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Botulinum neurotoxins: Future innovations
por: Brideau-Andersen, Amy, et al.
Publicado: (2023)

New botulinum neurotoxin constructs for treatment of chronic pain
por: Leese, Charlotte, et al.
Publicado: (2023)

Conjugative Botulinum Neurotoxin-Encoding Plasmids in Clostridium botulinum
por: Marshall, Kristin M., et al.
Publicado: (2010)

Detection of VAMP Proteolysis by Tetanus and Botulinum Neurotoxin Type B In Vivo with a Cleavage-Specific Antibody
por: Fabris, Federico, et al.
Publicado: (2022)

Emerging Opportunities for Serotypes of Botulinum Neurotoxins
por: Peng Chen, Zhongxing, et al.
Publicado: (2012)

Engineering of Botulinum Neurotoxins for Biomedical Applications
por: Webb, Robert P.
Publicado: (2018)

The Expanding Therapeutic Utility of Botulinum Neurotoxins
por: Fonfria, Elena, et al.
Publicado: (2018)

Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
por: Pirazzini, Marco, et al.
Publicado: (2017)

Botulinum Neurotoxin for the Treatment of Neuropathic Pain
por: Egeo, Gabriella, et al.
Publicado: (2020)

Tables of Toxicity of Botulinum and Tetanus Neurotoxins
por: Rossetto, Ornella, et al.
Publicado: (2019)

Botulinum Neurotoxin Injections in Childhood Opisthotonus
por: Hull, Mariam, et al.
Publicado: (2021)

Recent Developments in Botulinum Neurotoxins Detection
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2022)

Botulinum Neurotoxins: From Toxin to Medicine
por: Santamato, Andrea
Publicado: (2023)

Optimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A–F Employing Taguchi Design-of-Experiments
por: von Berg, Laura, et al.
Publicado: (2019)

The Zinc-Dependent Protease Activity of the Botulinum Neurotoxins
por: Lebeda, Frank J., et al.
Publicado: (2010)

Neurologic uses of botulinum neurotoxin type A
por: Ney, John P, et al.
Publicado: (2007)

Tyrosine Phosphorylation of Botulinum Neurotoxin Protease Domains
por: Toth, Stephen, et al.
Publicado: (2012)

Botulinum Neurotoxin Detection and Differentiation by Mass Spectrometry
por: Barr, John R., et al.
Publicado: (2005)

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
por: Schaefer, Sara M., et al.
Publicado: (2015)

Botulinum Neurotoxin Type A in Neurology: Update
por: Orsini, Marco, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_00f81ipfnajnk0fg4u00hid0og